K-numberK250636
Device nameSophy Mini Monopressure Valve (SM1)
ApplicantSophysa
Product codeJXG
Device classClass II
Decision dateNov 28, 2025
DecisionSubstantially Equivalent
Regulation882.5550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Sophy Mini Monopressure Valve is a cerebrospinal fluid (CSF) shunt valve designed to treat hydrocephalus by diverting excess CSF from the brain's ventricular cavities to either the abdominal cavity or the right atrium of the heart. It is a single-use, sterile device sterilized with ethylene oxide and can be used in patients of all ages except pre-term infants.

Technological characteristics

The SM1 uses the same ball-in-cone design principle as the predicate Polaris valve with a ruby ball on a spring's curvature to regulate pressure. Key differences include: the SM1 has no magnets (versus two micro magnets in Polaris), a fixed rotor (versus movable), no shuttle mechanism, and no pressure adjustment capability. It is available in three fixed pressure settings (50, 110, 170 mmH₂O) versus Polaris's four adjustable pressure ranges. Dimensions are nearly identical (0.1 mm thinner: 16 mm diameter × 32.5 mm length × 4.9 mm thickness).

Test standards cited

ISO 7197, ASTM F647, ASTM F640, ASTM F2052, ASTM F2213, ASTM F2182, and ISO 20698. Testing included radiopacity, leakage resistance, pressure-flow characteristics, dynamic breaking strength, reflux performance, shock resistance, dimensional control, long-term stability, posture effects, burst and overpressure testing, MRI compatibility, visual inspection, and hydrodynamic resistance.

Substantial equivalence argument

The SM1 is substantially equivalent to the Polaris Adjustable Pressure Valve (K141227) because both share the same intended use, identical clinical indications, same materials and sterilization method, and substantially similar ball-in-cone design with equivalent pressure ranges. The absence of magnets and adjustable features in the SM1 simplifies the design without compromising safety or effectiveness, actually improving MRI compatibility. All bench testing passed acceptance criteria, demonstrating equivalent or superior performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →